Clinical Trial Update: A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of a conversion study evaluating switching from Hectorol Injection to Hectorol Capsules in stage 5 chronic ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED